Protagonist Therapeutics (PTGX) PTG-300 Data is Misunderstood, Nomura Reiterates $29 PT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
Go back to Protagonist Therapeutics (PTGX) PTG-300 Data is Misunderstood, Nomura Reiterates $29 PT
December 4, 2019 9:47 AM EST
Protagonist Therapeutics (NASDAQ: PTGX) Halted on LUDP, Up 59%
...
More